The global Blood Collection Market was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.3 billion in 2026 to USD 8.2 billion by 2033, registering a CAGR of 6.3% from 2026 to 2033. The market continues to expand due to the rising volume of diagnostic procedures, increasing prevalence of chronic and infectious diseases, and growing demand for accurate laboratory...

The global Drug Delivery Devices Market was valued at USD 463.8 billion in 2025 and is projected to reach USD 841.4 billion by 2033, expanding at a CAGR of 7.8% from 2026 to 2033. Market growth is being fueled by the increasing adoption of advanced drug administration technologies, rising prevalence of chronic diseases, and growing demand for precision medicine solutions that improve...

The global Patient Monitoring Devices Market was valued at USD 54.3 billion in 2025 and is projected to grow from USD 58.9 billion in 2026 to USD 118.2 billion by 2033, registering a CAGR of 10.5% from 2026 to 2033. North America accounted for the largest revenue share of 34.9% in 2025, driven by advanced healthcare infrastructure, strong adoption of digital health technologies, and...

Access to quality healthcare is no longer limited to hospitals and clinics, thanks to the growing popularity of home-based medical care. One of the most convenient solutions available today is Home Injection Service Dubai, which allows patients to receive safe and professional injectable treatments without leaving their homes. With increasing reliance on Doctor at Home in services, patients can...

According to a newly published market research report by 24LifeSciences, the global Bluetooth blood glucose meter market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period 2025–2032. A Bluetooth blood glucose meter is an advanced medical device designed...

The report "Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application), Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030", is projected to reach 61.2 billion in 2030 from USD 34.3 billion in 2025, at a CAGR of 12.3% during the forecast...

Diabetes testing systems are foundational to effective disease management, enabling timely diagnosis, continuous glucose tracking, and informed therapeutic decision-making. Their importance within the healthcare and life sciences ecosystem continues to grow as healthcare systems worldwide shift toward preventive care, patient-centric monitoring, and data-driven disease management strategies....

The Europe Medical Drug‑releasing Micropump market was valued at USD 0.35 billion in 2025 and is projected to grow from USD 0·38 billion in 2026 to USD 0·64 billion by 2034, exhibiting a CAGR of 9·3% during the forecast period. A Medical Drug‑releasing Micropump is a miniature infusion device designed for precise, controlled, and continuous drug delivery. These systems...

According to a new report from Intel Market Research, the global Calcitriol market was valued at USD 347 million in 2025 and is projected to reach USD 438 million by 2034, growing at a steady CAGR of 3.5% during the forecast period (2025–2034). This growth is driven by the rising prevalence of chronic kidney disease, expanding therapeutic applications in bone and skin disorders, and...

According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...